AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals

SAN DIEGO–(BUSINESS WIRE)–AlivaMab Discovery Services has entered a discovery agreement with Teva Pharmaceuticals to generate antibodies for multiple therapeutic programs.
Click here to view original post